The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms

Abdominal aortic aneurysms (AAA) have a prevalence between 1.3-8.9% in men and 1.0-2.2% in women aged above 55 years. Furthermore, AAA cause 1-3% of all deaths among men aged 65-85 years in developed countries. As the disorder is invariably associated with severe atherosclerotic damage of the arterial wall, it has traditionally been regarded as a direct consequence of generalized atherosclerotic disease. In patients with occlusive aortic disease, dyslipidemiais a well established risk factor. However, in patients with aneursymatic aortic disease, the association between dyslipidemiaand the development of AAA is less clear. Large clinical trials in patients with cardiac and peripheral arterial disease have shown the strong relation between dyslipidemia, statintherapy and the risk of cardiovascular disease. Importantly, the effects of statintherapy were still present irrespective of the decrease in serum cholesterol levels. These findings resulted in the discussion of potential non-lipid lowering effects of statintherapy. These "pleiotropic effects" compose a diversity of cellular events which have an effect on several components of the arterial wall, including: 1) endothelial cells; 2) smooth muscle cells; 3) platelets; 4) monocytes/macrophages; and 5) the process of inflammation. In the general population the role of dyslipidemiaas an independent risk factor for AAA is debated. However, as patients with AAA frequently have concomitant arterial disease, statintherapy is often recommended. As a result, the non-lipid lowering effects of statinson aneurysm expansion rate are hardly studied, and most evidence comes from experimental and animal studies. In the current review article we provide an overview of all available literature on the effects of dyslipidemia, statintherapy and the risk of AAA expansion and rupture. In the first part we summarize all population-based studies that investigated the relation between hypercholesterolemia and the development of AAA. In the second part, the available literature regarding the effects of statinson aneurysm growth, expansion rate and the risk of rupture is summarized, including in vitro, animal and clinical human studies.